Hematology - European Medical Journal

This site is intended for healthcare professionals

Continue

Hematology

Filter
EMJ
3 Mins
7 May 2015

Subclinical Hypothyroidism and its Impact on Reproductive Health

Subclinical hypothyroidism (SCH) is defined by elevated thyroid-stimulating hormone (TSH) levels in the presence of normal thyroxine (T4) levels.
EMJ
3 Mins
10 Mar 2015

Below the Belt, Experiences with Prostate Cancer

There is a new guy on the block. A new guy in the guise of a book written by new-age men talking about their very own personal experiences of their…
EMJ
23 Feb 2015

Virtual Blood Could Be the Key to More Effective Treatments for Blood Cancers

DEVELOPMENT of treatments for leukaemia and lymphoma could be aided by a new computer model that simulates the development of blood cells…
17 Feb 2015

Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3)

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society…
17 Feb 2015

ASH 2014: Recent investigational advances in mantle cell lymphoma treatment

Prof Simon Rule (Derriford Hospital, Plymouth, UK) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses recent advances in the…
EMJ
17 Feb 2015

ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 2)

Dr Jia Ruan (Weill Cornell Medical College, New York, NY) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses the clinical relevance…
EMJ
17 Feb 2015

Prof John Gribben and Prof Marek Trněný at ASH 2014: Mantle cell lymphoma advances (Part 1)

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) and Prof Marek Trněný (Charles…
EMJ
17 Feb 2015

ASH 2014: New therapies for mantle cell lymphoma

Prof Umberto Vitolo (Città della Salute e della Scienza di Torino, Turin, Italy) at the 2014 American Society of Hematology (ASH) Annual Meeting…
We’ve noticed you’re accessing
from North/South America.